GO:0002553 histamine secretion by mast cell: Regulated Exocytosis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002553 describes the regulated release of histamine by a mast cell or group of mast cells.
• Histamine secretion from mast cells is a calcium-dependent exocytotic process that requires IgE receptor or MRGPRX2 activation.
• Mast cell histamine is stored in cytoplasmic granules and released upon degranulation, contributing to anaphylaxis, pain, and neuroinflammation.
• Key molecular players include FcεRI, MRGPRX2, HRH1, TRPV1, and phosphodiesterases that modulate cAMP levels.
• Dysregulated histamine secretion is implicated in diabetic peripheral neuropathy, endometriosis pain, cholangiocarcinoma, and mast cell activation syndrome.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of genes controlling mast cell histamine release.
Description
Histamine secretion by mast cell (GO:0002553) is the regulated release of histamine by a mast cell or group of mast cells. This biological process is central to immediate hypersensitivity, anaphylaxis, and neuroimmune interactions. Mast cells store histamine in cytoplasmic granules and release it upon activation through IgE-dependent or IgE-independent pathways. The process is tightly controlled by intracellular calcium, cAMP, and phosphodiesterase activity. Researchers study GO:0002553 to understand allergic diseases, pain, cancer microenvironment, and metabolic complications such as diabetic peripheral neuropathy. Because histamine is a potent vasoactive and neurotransmitter mediator, its secretion must be precisely regulated to avoid systemic pathology. This article integrates QuickGO definition and verified PubMed literature to provide a research-grade overview of the genes, mechanisms, and experimental models relevant to histamine secretion by mast cell.
histamine secretion by mast cell At A Glance
| GO ID | GO:0002553 |
|---|---|
| GO term | histamine secretion by mast cell |
| Ontology | biological_process |
| Synonym | none |
| Major function | Regulated release of histamine from mast cell granules |
| Cellular location | Mast cell cytoplasmic granules and plasma membrane |
| Key triggers | FcεRI crosslinking, MRGPRX2 activation, calcium influx |
| Major mediators | Histamine, tryptase, cytokines |
| Associated diseases | Anaphylaxis, endometriosis pain, diabetic neuropathy, cholangiocarcinoma |
What Is GO:0002553?
GO:0002553 is defined by QuickGO as the regulated release of histamine by a mast cell or group of mast cells. In practice, this means the calcium-triggered fusion of histamine-containing granules with the plasma membrane, followed by extracellular release of histamine. The term encompasses both IgE-mediated and non-IgE-mediated activation pathways, including MRGPRX2-dependent secretion.
Why Is histamine secretion by mast cell Important in Cell Biology?
Histamine secretion by mast cells is a critical effector mechanism in allergic inflammation, anaphylaxis, and neuroimmune signaling. It also contributes to cancer progression and metabolic complications, making it a target for therapeutic intervention. Understanding GO:0002553 helps researchers design experiments to modulate mast cell activity in disease models.
• Mediates IgE-mediated systemic anaphylaxis through histamine release.
• Drives MRGPRX2-dependent pain in endometriosis via histamine/HRH1/TRPV1 signaling.
• Contributes to diabetic peripheral neuropathy progression in mice.
• Modulates cholangiocarcinoma microenvironment through mast cell-bile interplay.
• Underlies mast cell activation syndrome, a multisystem disorder.
• Regulated by phosphodiesterases and cAMP in human skin mast cells.
• Involved in mast cell maturation and IgE responses.
• Serves as a biomarker for mast cell activation beyond histamine and tryptase.
• Provides a target for anti-histamine and mast cell stabilizer therapies.
• Enables CRISPR-based dissection of granule exocytosis machinery.
What Happens During histamine secretion by mast cell?
Mast cell activation and calcium signaling
In simple terms: Mast cells receive a trigger that opens calcium channels, which is the first step for releasing histamine.
Activation of mast cells through FcεRI crosslinking by IgE or through MRGPRX2 by basic secretagogues leads to intracellular calcium mobilization. Calcium influx is required for granule-plasma membrane fusion and subsequent histamine release. This step is modulated by phosphodiesterases that degrade cAMP, thereby influencing the threshold for secretion.
Granule translocation and docking
In simple terms: Histamine-containing granules move to the cell surface and get ready to fuse.
Upon calcium elevation, cytoplasmic histamine-containing granules translocate along microtubules to the plasma membrane. Docking involves SNARE proteins and regulatory factors that are still being characterized in mast cells. This stage is sensitive to cAMP levels and PDE activity.
Membrane fusion and histamine release
In simple terms: The granule membrane fuses with the cell membrane, spilling histamine outside.
Granule-plasma membrane fusion results in the extracellular release of histamine along with other preformed mediators such as tryptase. This process is rapid and can be triggered within minutes of activation. Histamine then acts on local HRH1 receptors, as shown in endometriosis pain models.
Receptor-mediated feedback and resolution
In simple terms: After release, histamine can feed back to regulate mast cells and nearby cells.
Histamine released from mast cells can bind HRH1 on sensory neurons, leading to TRPV1 sensitization and pain. In systemic anaphylaxis, histamine contributes to vasodilation and shock. Mast cell activation is also linked to diabetic milieu-induced dysregulation in peripheral neuropathy.
Key Genes Involved in GO:0002553 histamine secretion by mast cell
The following genes and proteins are experimentally implicated in histamine secretion by mast cells based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FcεRI | High-affinity IgE receptor; triggers mast cell activation | IgE-mediated anaphylaxis models |
| MRGPRX2 | G-protein coupled receptor for basic secretagogues | Non-IgE mast cell activation and pain |
| HRH1 | Histamine receptor 1 on sensory neurons | Histamine/HRH1/TRPV1 pain signaling |
| TRPV1 | Ion channel sensitized by histamine | Endometriosis pain and neuroinflammation |
| PDE | Phosphodiesterase; regulates cAMP | Modulates histamine release in skin mast cells |
| IgE | Immunoglobulin E; binds FcεRI | Mast cell maturation and anaphylaxis |
| Tryptase | Mast cell protease co-released with histamine | Mast cell activation biomarker |
| IL-6 | Cytokine released by mast cells | Mast cell activation syndrome |
| TNF | Cytokine released by mast cells | Mast cell activation syndrome |
| Chymase | Mast cell protease | Mast cell activation syndrome |
| Histidine decarboxylase | Enzyme synthesizing histamine | Histamine production in mast cells |
| SNARE proteins | Mediate granule fusion | Exocytosis machinery |
| Calcium channels | Mediate calcium influx | Trigger for histamine release |
| MRGPRX2 ligands | Basic secretagogues | Non-IgE activation |
| HRH2 | Histamine receptor 2 | Feedback regulation |
| HRH4 | Histamine receptor 4 | Mast cell modulation |
| cAMP | Second messenger | Regulates secretion threshold |
How Is histamine secretion by mast cell Regulated?
Histamine secretion by mast cells is regulated by intracellular cAMP levels, with phosphodiesterase inhibitors modulating release in human skin mast cells. Calcium signaling is a central trigger, and MRGPRX2 activation provides an IgE-independent pathway. IgE binding to FcεRI regulates mast cell maturation and subsequent histamine release. Diabetic milieu can dysregulate mast cell activation, exacerbating peripheral neuropathy. Additionally, mast cell activation syndrome involves dysregulated release of histamine and other mediators.
histamine secretion by mast cell and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FcεRI | Systemic anaphylaxis | Knockout mouse |
| MRGPRX2 | Endometriosis pain | Knockout or knockdown in mice |
| HRH1 | Pain sensitization | Point mutation or knockout |
| PDE | Skin mast cell histamine release | Overexpression or inhibitor studies |
| IgE | Mast cell maturation | Knock-in or transgenic |
Anaphylaxis and allergic disorders
Mast cell histamine secretion is critical for IgG-mediated systemic anaphylaxis, as shown in mouse models. IgE and histamine also play roles in mast cell maturation, linking to allergic sensitization. Mast cell activation syndrome is a clinical entity characterized by dysregulated mediator release, including histamine.
Endometriosis pain
MRGPRX2 mediates mast cell-induced endometriosis pain through histamine/HRH1/TRPV1 signaling, demonstrating a direct link between histamine secretion and nociception.
Diabetic peripheral neuropathy
Dysregulated mast cell activation induced by diabetic milieu exacerbates diabetic peripheral neuropathy in mice, implicating histamine secretion in metabolic neuropathy.
Cholangiocarcinoma
Mast cell and bile-cholangiocarcinoma interplay in the tumor microenvironment involves mast cell function, potentially including histamine secretion.
From histamine secretion by mast cell-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FcεRI mediate histamine secretion in anaphylaxis? | FcεRI knockout mouse |
| Does MRGPRX2 drive endometriosis pain via histamine? | MRGPRX2 knockout mouse |
| Does PDE regulate histamine release? | PDE overexpression or knockout in mast cells |
| Does IgE affect mast cell maturation? | IgE knock-in or transgenic mouse |
| Does diabetic milieu alter mast cell histamine secretion? | Streptozotocin-induced diabetic mouse |
| Does histamine contribute to cholangiocarcinoma microenvironment? | Mast cell-deficient mouse models |
How to Study the histamine secretion by mast cell Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Histamine ELISA | Histamine concentration | Mast cell activation |
| Calcium imaging | Intracellular calcium | Activation upstream of secretion |
| CRISPR knockout | Gene function | Causal role in histamine release |
| RNA-seq | Transcriptome changes | Mast cell activation signatures |
| Proteomics | Protein expression | Granule components |
| Flow cytometry | Mast cell degranulation markers | Mast cell activation syndrome |
| Western blot | Signaling proteins | FcεRI and MRGPRX2 pathways |
| Mouse models | In vivo histamine effects | Anaphylaxis and pain |
Measuring histamine release
Histamine secretion can be quantified by enzyme immunoassay or fluorometric methods from mast cell supernatants after activation. These assays are standard for assessing GO:0002553 activity.
Calcium imaging
Intracellular calcium flux is measured using fluorescent dyes to monitor mast cell activation upstream of histamine release.
Genetic knockout and knockdown
CRISPR-Cas9 knockout of FcεRI, MRGPRX2, or PDE genes in mast cell lines or mice allows causal testing of histamine secretion.
Transcriptomics and proteomics
RNA-seq and proteomics can identify genes and proteins co-regulated with histamine secretion in mast cells.
How CRISPR Can Be Used to Study GO:0002553 histamine secretion by mast cell
Knockout
CRISPR knockout of FcεRI, MRGPRX2, or PDE genes in mast cells or mice can abolish or reduce histamine secretion, providing causal evidence for GO:0002553.
Point Mutation
Point mutations in HRH1 or TRPV1 can dissect signaling residues required for histamine-mediated pain sensitization.
Knock-in
Knock-in of tagged histamine granule proteins or reporters allows live imaging of granule trafficking during secretion.
Overexpression
Overexpression of PDE or IgE can enhance or suppress histamine release, enabling dose-response studies.
How EDITGENE Supports histamine secretion by mast cell Research
Researchers studying histamine secretion by mast cell-related genes often need to determine whether a candidate gene is causally involved in granule exocytosis, receptor signaling, or mediator release. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for histamine secretion by mast cell research.
Frequently Asked Questions About histamine secretion by mast cell
What is histamine secretion by mast cell GO:0002553?
It is the regulated release of histamine by a mast cell or group of mast cells, as defined by QuickGO.
What genes are involved in histamine secretion by mast cell?
Key genes include FcεRI, MRGPRX2, HRH1, TRPV1, PDE, IgE, and histidine decarboxylase.
How is histamine released from mast cells?
Through calcium-dependent granule exocytosis triggered by FcεRI or MRGPRX2 activation.
What diseases involve mast cell histamine secretion?
Anaphylaxis, endometriosis pain, diabetic peripheral neuropathy, cholangiocarcinoma, and mast cell activation syndrome.
What is the role of MRGPRX2 in histamine secretion?
MRGPRX2 mediates IgE-independent mast cell activation and histamine release, contributing to pain.
How do phosphodiesterases regulate histamine release?
PDE inhibitors modulate cAMP levels and histamine release in human skin mast cells.
Can CRISPR knockout be used to study histamine secretion?
Yes, knockout of FcεRI, MRGPRX2, or PDE genes can abolish or reduce histamine release.
What models are used for histamine secretion research?
Mouse models of anaphylaxis, endometriosis, and diabetic neuropathy, as well as mast cell lines.
What is mast cell activation syndrome?
A multisystem disorder characterized by dysregulated release of histamine and other mast cell mediators.
How does histamine cause pain in endometriosis?
Histamine released from mast cells binds HRH1 on sensory neurons, sensitizing TRPV1 and causing pain.
Conclusion
GO:0002553 histamine secretion by mast cell is a fundamental biological process with broad implications for allergy, pain, cancer, and metabolic disease. Understanding its molecular regulation and genetic control is essential for developing targeted therapies. CRISPR-based models and EDITGENE services provide powerful tools to dissect this process and identify novel therapeutic targets.
References
- 1. Yao X et al.. 2025. Dysregulated mast cell activation induced by diabetic milieu exacerbates the progression of diabetic peripheral neuropathy in mice.. Nat Commun 16(1):4170 PMID: 40325050
- 2. Khodoun MV et al.. 2025. Importance of mast cell histamine secretion in IgG-mediated systemic anaphylaxis.. J Allergy Clin Immunol 155(3):956-973 PMID: 39550048
- 3. Shi A et al.. 2024. Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment.. Gut 73(8):1350-1363 PMID: 38458750
- 4. Mao X et al.. 2025. MRGPRX2 Mediates Mast Cell-Induced Endometriosis Pain Through the Sensitization of Sensory Neurons via Histamine/HRH1/TRPV1 Signaling Pathway.. FASEB J 39(13):e70778 PMID: 40600649
- 5. Theoharides TC et al.. 2023. Mast cell activation: beyond histamine and tryptase.. Expert Rev Clin Immunol 19(6):639-654 PMID: 37029958
- 6. Frieri M. 2018. Mast Cell Activation Syndrome.. Clin Rev Allergy Immunol 54(3):353-365 PMID: 25944644
- 7. Tanaka S et al.. 2021. Roles of IgE and Histamine in Mast Cell Maturation.. Cells 10(8) PMID: 34440939
- 8. Eskandari N et al.. 2015. Regulation of human skin mast cell histamine release by PDE inhibitors.. Allergol Immunopathol (Madr) 43(1):37-41 PMID: 24231152
